Anna Kazanchyan

Anna Kazanchyan

Fundador en Primary I-Research LLC .

55 años
Health Technology
Consumer Services
Finance

Perfil

Anna Kazanchyan has founded two companies.
Primary I-Research LLC was founded in 2004, where she holds the title of Managing Partner.
Saghmos Therapeutics, Inc. was founded in 2017, where she holds the title of Chief Executive Officer.
Dr. Kazanchyan's former jobs include being an Independent Director at VYNE Pharmaceuticals Ltd.
from 2014 to 2020, Director at High Point Chamber of Commerce, Independent Director at 9 Meters Biopharma, Inc., Senior Vice President-Business Development at Ovid Therapeutics, Inc., and Analyst at Wachovia Securities LLC in 2002.
Dr. Kazanchyan's education includes an undergraduate degree from Clark University and a doctorate from Harvard Medical School.

Cargos activos de Anna Kazanchyan

EmpresasCargoInicio
Primary I-Research LLC Fundador 01/04/2004
Director Ejecutivo 01/09/2017
Todos los cargos activos de Anna Kazanchyan

Antiguos cargos conocidos de Anna Kazanchyan.

EmpresasCargoFin
Director/Miembro de la Junta 09/03/2020
9 METERS BIOPHARMA, INC. Director/Miembro de la Junta 12/06/2018
Analyst-Equity 11/03/2002
Director/Miembro de la Junta -
OVID THERAPEUTICS INC. Corporate Officer/Principal -
Ver el detalle de la experiencia de Anna Kazanchyan.

Formación de Anna Kazanchyan.

Clark University Undergraduate Degree
Harvard Medical School Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Anna Kazanchyan.

Relaciones

18

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
OVID THERAPEUTICS INC.

Health Technology

9 METERS BIOPHARMA, INC.

Health Technology

Empresas privadas5

Health Technology

Finance

Commercial Services

Primary I-Research LLC

Health Technology

Ver las conexiones de la empresa
-40% Prolongación excepcional: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA